Advances in Bioscience and Biotechnology

Advances in Bioscience and Biotechnology

ISSN Print: 2156-8456
ISSN Online: 2156-8502
www.scirp.org/journal/abb
E-mail: abb@scirp.org
"Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments"
written by Diana Gil, Adam G. Schrum,
published by Advances in Bioscience and Biotechnology, Vol.4 No.4A, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Autoimmune encephalitis: novel therapeutic targets at the preclinical level
2021
[2] The Application of Nanobody in CAR-T Therapy
2021
[3] The antigen‐binding moiety in the driver's seat of CARs
2021
[4] IL13R⍺ 2-CAR T cells for Immunotherapy of Glioblastoma
2021
[5] The Application of Nanobody in CAR-T Therapy. Biomolecules 2021, 11, 238
2021
[6] Autoinduction as Means for Optimization of the Heterologous Expression of Recombinant Single-Chain Fv (scFv) Antibodies
2021
[7] Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation
2021
[8] CAR-NK Cells in the Treatment of Solid Tumors
2021
[9] Advances in point-of-care testing for cardiovascular diseases
2020
[10] Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation
2020
[11] Protection of Alcohol Dehydrogenase against Freeze–Thaw Stress by Ice-Binding Proteins Is Proportional to Their Ice Recrystallization Inhibition Property
2020
[12] Live long and active: Polypeptide-mediated assembly of antibody variable fragments
2020
[13] CAR-T design: Elements and their synergistic function
2020
[14] Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments
2020
[15] Development of active tumor targeting systems for delivery of siRNA and drugs into breast and colorectal cancer
2020
[16] Public and private human T cell clones respond differentially to HCMV antigen when boosted by CD3 co-potentiation
2020
[17] Driving CARs with alternative navigation tools–the potential of engineered binding scaffolds
2020
[18] CAR-T-Zellen erkennen und eliminieren den Thyreotropin-Rezeptor exprimierende differenzierte Schilddrüsenkarzinomzellen
2020
[19] Calcium-dependent affinity ligands for protein purification
2020
[20] ШАПЕРОННАЯ И ИММУНОГЛОБУЛИНСВЯЗЫВАЮЩАЯ АКТИВНОСТИ Skp ИЗ Yersinia pseudotuberculosis
2020
[21] Exploring and exploiting the minor pilins of Type IV pili
2019
[22] Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development
2019
[23] Chaperone and Immunoglobulin-Binding Activities of Skp Protein from Yersinia pseudotuberculosis
Biochemistry (Moscow), 2019
[24] Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex
2019
[25] Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage
Materials Horizons, 2019
[26] Amino acid induced hyper activation of laccase and its application in dye degradation
2019
[27] Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono-and Bi-specific Antitumor Activity of T Cells
2019
[28] Improving developability of an Antigen Binding Fragment by Aspartate Substitutions
2019
[29] An Antibody Fab Fragment-based Chimeric Antigen Receptor Could Efficiently Eliminate Human Thyroid Cancer Cells
2019
[30] Design and Production of Bispecific Antibodies
2019
[31] Developing VHH-based tools to study Ebolavirus infection
2019
[32] Pre-clinical development of novel ROR1 chimeric antigen receptor T cells and bispecific T cell engagers
2018
[33] Introduction into Novel Constructs
Challenges in Protein Product Development, 2018
[34] Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae
Protein Expression and Purification, 2018
[35] Strategies to Address Chimeric Antigen Receptor Tonic Signaling
2018
[36] Expression and neutralization capacity of single domain HIV antibody fragments
2018
[37] Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells
mAbs, 2018
[38] Bacterial communities adapted to higher external resistance can reduce the onset potential of anode in microbial fuel cells
2018
[39] Optimizing Antibody Expression: the nuts and Bolts
Methods, 2017
[40] Development of humanized scFv antibody fragment (s) that targets and blocks specific HLA alleles linked to myasthenia gravis
Applied Microbiology and Biotechnology, 2017
[41] Molecular Effects of Concentrated Solutes on Protein Hydration, Dynamics, and Electrostatics
Biophysical Journal, 2016
[42] Antibody Aggregation: Insights from Sequence and Structure
Antibodies, 2016
[43] Testing the anti-fibrotic potential of the single-chain Fv antibody against the α 2 C-terminal telopeptide of collagen I
Connective tissue research, 2013
Free SCIRP Newsletters
Copyright © 2006-2022 Scientific Research Publishing Inc. All Rights Reserved.
Top